Athersys (NASDAQ:ATHX) Now Covered by StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHXGet Free Report) in a research note issued on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Price Performance

Shares of NASDAQ ATHX opened at $0.01 on Monday. The firm has a market cap of $833,206.50, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 1 year low of $0.01 and a 1 year high of $1.99.

About Athersys

(Get Free Report)

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.

Further Reading

Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.